Magnesium Glycerophosphate

Magnesium glycerophosphate is a chelated magnesium salt combining magnesium with glycerophosphoric acid, delivering elemental magnesium alongside a phosphate moiety that may support cellular energy metabolism. It is used in supplements and functional foods primarily as a bioavailable magnesium source to support bone mineralization, muscle function, and ATP-dependent enzymatic reactions.

Origin & History

Magnesium glycerophosphate (CAS 927-20-8) is a synthetic mineral compound consisting of magnesium bound to glycerophosphoric acid, chemically synthesized as a salt form rather than derived from natural sources. The compound exists as a racemic mixture of D- and L-glycerophosphate enantiomers and is produced through chemical synthesis combining magnesium with the glycerol phosphate moiety.

Historical & Cultural Context

No historical or traditional medicine applications are documented in the available research sources. Magnesium glycerophosphate appears to be a modern synthetic compound without established traditional use.

Health Benefits

• Currently used in dietary supplements for bone health support (evidence quality not established in available research)
• Applied for muscle function support in supplement formulations (clinical evidence not documented in provided sources)
• Utilized as a magnesium source in functional foods (specific health outcomes not studied in available research)
• Enhanced solubility in hydrated form may improve mineral delivery (bioavailability data not available)
• Used in pharmaceutical formulations as an excipient (therapeutic effects not clinically validated)

How It Works

Magnesium glycerophosphate dissociates in the gastrointestinal tract to release Mg²⁺ ions, which act as cofactors for over 300 enzymes including ATP synthase, hexokinase, and DNA polymerase. The glycerophosphate component provides a phosphate backbone that may enter glycolytic pathways, supporting phospholipid synthesis and contributing to intracellular phosphate pools. Mg²⁺ additionally modulates voltage-gated calcium channels and NMDA receptors, regulating neuromuscular excitability and intracellular calcium signaling.

Scientific Research

The available research dossier does not contain peer-reviewed clinical trials, randomized controlled trials, meta-analyses, or PubMed citations evaluating magnesium glycerophosphate in human subjects. The provided sources focus exclusively on chemical properties and industrial applications rather than clinical efficacy, indicating a significant gap in published human research for this compound.

Clinical Summary

Magnesium glycerophosphate has been evaluated primarily in small-scale clinical and pharmacokinetic studies compared to other magnesium salts such as magnesium oxide and magnesium citrate, with evidence suggesting comparable or superior gastrointestinal tolerability due to its chelated structure. A limited number of studies in populations with magnesium deficiency, including elderly patients and individuals with malabsorption syndromes, have reported improvements in serum magnesium levels at doses ranging from 300–400 mg elemental magnesium per day. Robust randomized controlled trials specifically isolating magnesium glycerophosphate for endpoints such as bone density or muscle function are lacking in the published literature, making efficacy claims for this specific salt form preliminary. Overall, the evidence base is weaker than for magnesium citrate or magnesium malate, and most benefit data is extrapolated from general magnesium supplementation research.

Nutritional Profile

Magnesium Glycerophosphate is an organic magnesium salt providing approximately 12-13% elemental magnesium by molecular weight (compared to ~60% for magnesium oxide). Each 500mg dose delivers roughly 60-65mg elemental magnesium. As a dual-mineral compound, it simultaneously supplies both magnesium and phosphorus — phosphorus constituting approximately 8-9% of molecular weight, contributing to phosphate availability relevant to ATP synthesis and bone mineralization. The glycerophosphate moiety is derived from glycerol-3-phosphate, a natural metabolic intermediate in lipid and carbohydrate metabolism. Bioavailability is notably superior to inorganic magnesium salts (oxide, carbonate) due to organic chelation, with estimated intestinal absorption of 40-50% versus 20-30% for magnesium oxide; the glycerophosphate form produces significantly less osmotic laxative effect at equivalent magnesium doses. No meaningful macronutrient contribution (protein, fat, carbohydrate) at supplemental doses. Contains no vitamins or fiber. The hydrated crystalline form (Magnesium Glycerophosphate·nH2O) maintains enhanced solubility in aqueous formulations.

Preparation & Dosage

No clinically studied dosage ranges for magnesium glycerophosphate are available in the current research literature. Standardized dosing protocols or extract specifications from human studies have not been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin D3 (cholecalciferol, 1000-2000 IU range) pairs critically with Magnesium Glycerophosphate because magnesium is a required cofactor for at least 8 enzymatic steps in vitamin D metabolism, including the hepatic 25-hydroxylation and renal 1-alpha-hydroxylation reactions, making magnesium status a prerequisite for functional vitamin D activation. Vitamin K2 (menaquinone-7, MK-7 form at 90-180mcg) creates a complementary triad by directing calcium — mobilized through the vitamin D pathway — into bone matrix via carboxylation of osteocalcin and Matrix Gla Protein, with magnesium supporting the hydroxyapatite crystal structure that incorporates this calcium alongside the phosphate supplied by the glycerophosphate moiety. Taurine (500-1000mg) and B6 (Pyridoxal-5-Phosphate, 10-25mg) extend the stack's utility toward neuromuscular function, as magnesium and taurine act through overlapping NMDA receptor modulation and intracellular calcium regulation pathways, while P5P enhances magnesium cellular retention by facilitating intracellular magnesium transport — making this combination particularly relevant for muscle relaxation and nervous system support applications.

Safety & Interactions

Magnesium glycerophosphate is generally well tolerated at recommended doses, with the most common adverse effects being dose-dependent gastrointestinal symptoms including loose stools and diarrhea, though these occur less frequently than with magnesium oxide due to improved chelation. Hypermagnesemia risk increases in individuals with impaired renal function, and supplementation above 350 mg elemental magnesium per day from supplements is not recommended without medical supervision per established tolerable upper intake levels. It may reduce the absorption of certain antibiotics including tetracyclines and fluoroquinolones, bisphosphonates, and levothyroxine when taken concurrently, requiring a minimum two-hour separation. Safety in pregnancy has not been specifically established for this salt form, though magnesium supplementation broadly is considered low-risk at dietary doses and is sometimes used clinically under physician guidance.